ScanGrants is a public service listing of grants and other funding types to support health research, programs and scholarship.
56 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Request for Proposals: Mathilde Krim Fellowships in Basic Biomedical Research
Performance Period: October 1, 2014 – September 30, 2016
Letter of Intent Deadline: 4:00 PM EDT, Thursday, May 15, 2014
Applicant Eligibility and Qualifications
Hold a research or clinical doctorate completed between three and six years prior to April 17, 2014*
Be positioned to secure an independent research position no later than March 2017
Be mentored by an experienced investigator at the same U.S. or international nonprofit research institution who: (a) is qualified to oversee the proposed research; (b) has successfully supervised postdoctoral fellows; and (c) is at the associate professor level or higher.
Be the main author on significant publications in leading international peer-reviewed journals
Have made oral and poster presentations at major scientific conferences and meetings
*The three to six year period for applicants who have earned only an M.D. begins with the date they finished their internship.
Submission of Krim Fellowship letters of inquiry and applications is now an online process.
Call for Submissions: Microbiome Awards
Deadline for Submission is May 31, 12PM PST.
The Microbiome Awards provides young, extraordinary scientists with funding and recognition to carry out scientific work in the field of Microbiome research.
Entrants must have been awarded their Ph.D in the last 5 years
This is an international contest. Submissions to the Awards are admitted from any researcher regardless of age, gender, country of origin, background or religion.
Submissions will not be accepted from members of scientific groups supervised by any of the judges.
The research described in the submission must fall within the Microbiome field. Incomplete submissions or those that do not meet the requirements will be rejected.
MO BIO Laboratories, main sponsor of the Microbiome Awards is generously donating prizes for more than $10,000 in value to distribute among the awardees. The winner of the competition will receive a Research Package consisting of the analysis of 100 microbiome samples by the EMP consortium (*). The sample analysis includes Nucleic acid extraction (using MO BIO products) and targeted amplicon analysis (16S rDNA).
(*) All data generated by the EMP together with the physical and chemical contextual data provided by the researcher, will be made public through the EMP data portal www.microbio.me/emp. If the awardee chooses the privacy of the project, the prize will consist of MO BIO products for the correspondant amount of the prize.
The winning proposals will be selected based on scientific merit and originality by a Scientific Review Committee. Each winner will be contacted directly and then the names will be posted on the Microbiome Project website on September 15, 2014. All decisions are final.
Gilead Sciences Research Scholars Program in Pulmonary Arterial Hypertension
Application Deadline: August 01, 2014
The Program is designed to support basic science and clinical research in the field of pulmonary arterial hypertension. Areas of research may include, but are not limited to:
Basic science underlying PAH
Genetics of PAH
Pathophysiology of PAH
Epidemiology of PAH
Techniques for early diagnosis of PAH
The Program is designed to support new original research. Proposals with significant scientific overlap with funded research projects from a peer review agency or industry source will not be considered.
Applicants must meet the following requirements:
Hold an MD, DO, PhD, or equivalent degree at time of award
Be within 5 years of a faculty appointment in association with a research institution in the United States at the time of application
Have a strong career interest in PAH
Have a research mentor with extensive experience in the field of PAH
Be able to devote at least 50% of professional time to research (versus administrative, patient care, or teaching responsibilities)
Be able to complete the proposed research within the 2-year award period
An applicant must be a citizen, permanent resident of the United States, or hold a temporary nonimmigrant visa. This visa must be valid for the two-year award period (January 2, 2015 – December 31, 2016).
Submission Deadline: Midnight, Eastern Daylight Time, August 1, 2014.
No applications will be accepted after this date.
Applications must be completed online and submitted electronically with the required Supplementary Materials.
Applications must include the following Supplementary Materials as specified:
Completed Application Form (All fields must be completed or applicant will not be able to submit)
Applicant's curriculum vitae, resume, or NIH biosketch, inclusive of publications, if applicable
Mentor's NIH biosketch
Letter of support from mentor, which includes: mentor’s track record of productivity, funding, and success with prior trainees; detailed description of the mentoring plan, including available resources allocated to the proposed research project, provision of protected time and available laboratory facilities
Bibliography of relevant references (maximum of 20)
Detailed budget and completed budget summary
Certification of Faculty Appointment from mentor is required and must be submitted with the Application using the template provided on the Program website (Download Certification of Faculty Appointment Template)
Acknowledgement of Indirect Costs Limitation and of the terms of this award from your institution's grants department is required and must be submitted using the template provided on the Program website)
List of Current or Pending Applications for Funding, using the template provided on the Program website
For general inquires about the Research Scholars Program, please call or email:
Gilead Sciences Research Scholars Program in Pulmonary Arterial Hypertension
Attn: Research Scholars Program Coordinator
American Epilepsy Society Seed Grant Program
This program is intended to foster collaborative interactions between two or more established investigators* to make future grants related to epilepsy more competitive for larger awards, and to fuel multi-investigator projects. These small awards are designed to enable information exchange/technology transfer, travel of postdoctoral fellows between laboratories, and modest supplies for the project. These awards are designed to provide seed monies to investigators. Funds are total costs. No allowance for indirect costs will be awarded over the $20,000 maximum funding level.
*An established investigator is defined as having at least an Associate Professor or equivalent level appointment, and who has a history of successful NIH/NSF/VA funding. Their work can be focused on basic, translational, or clinical research.
• At least one PI must be an active member of the Society
• Must be a new initiative that will add value to the field or fill a gap in knowledge
• Techniques in a collaborative effort must be complementary
• Must involve two or more established investigators, at least one of which is an epilepsy-focused investigator.
• Although not required, trans-disciplinary projects, projects integrating clinical and basic research, and research directions with translational relevance are encouraged.
• Also encouraged are collaborations between geographically separated laboratories, or between laboratories in highly disparate scientific disciplines (e.g. neuroscience and engineering).
Funding: A maximum of five one-year grants in the amount of $20,000 each will be awarded annually. Grants are non-renewable.
Application should be no more than two pages not counting the face page and include:
a) a face page
b) an overview of the research and technical expertise of the participating laboratories/clinical research sites.
c) the research collaboration that is proposed,
d) how the seed grant mechanism will foster this research and the overall collaboration, and
e) a budget.
Applications should also include an NIH format Biosketch for all principal investigators, including present and past funding. This Biosketch should highlight the 5 most significant publications of each investigator published over the past 10 years,
There are three rounds of consideration each year. Applications will be reviewed by a committee of the Research & Training Council and results will be announced within six weeks of the application deadline.
Submission deadlines (no extensions):
• March 28, 2014
• June 27, 2014
• September 26, 2014
Applications (in PDF format) should be sent to the AES Office by email to firstname.lastname@example.org by close of business on the date of the deadline.
Grass Foundation-AES Young Investigator Travel Awards
To recognize and honor outstanding young investigators conducting research in basic or clinical neuroscience related to epilepsy, the Grass Foundation and the American Epilepsy Society have combined resources to present Grass Foundation-AES Young Investigator Travel Awards ($1,000, together with waiver of AES meeting registration fees) to up to 8 deserving candidates to help support travel costs to present their research at the annual meeting of the American Epilepsy Society. In addition, the AES will announce the awardees and their talk/poster titles in an award ceremony during the scientific program.
1. Candidates will be investigators early in their careers, including graduate students, postdoctoral fellows, residents, clinical fellows or junior faculty (M.D., M.D./Ph.D., Ph.D., or the equivalent), who are conducting basic or clinical research relating to epilepsy and are less than 5 years out of postgraduate training.
2. Applicants should be first authors on an abstract submitted to the AES
3. Applicants can self-nominate, or nominations from second parties will be accepted.
4. Following the initial review of application abstracts, as part of the application process, a recommendation may be required from one of the applicant’s trainers/mentors. This will be solicited by the AES review committee should the application be deemed competitive for the award. This recommendation should include the applicant’s research focus, role in the abstract, promise as a future investigator, and any information regarding the applicant’s status as an underrepresented minority.
1. Submit an abstract through the AES Online Submission program as first author and check off the Junior Investigator Travel Award box. Deadline for submitting abstracts is June 9, 2014.
2. Select the Grass Travel Award in the submitter and follow the instructions provided. A letter from your mentor is part of the application process.
3. You must be present at the 2014 AES Annual Meeting.
Call for Applications: Epilepsy Research Recognition Awards Program
The AES is pleased to announce the call for applications for the annual Epilepsy Research Recognition Awards Program. This is a public recognition program designed to encourage and reward clinical and basic science investigators whose research contributes importantly to understanding and conquering epilepsy. Funds for the program have been generously provided by the American Epilepsy Society.
The American Epilepsy Society is one of the oldest neurological professional organizations in the United States. The Society seeks to promote interdisciplinary communication, scientific investigation, and exchange of clinical information about epilepsy. Membership consists of clinicians, scientists investigating basic and clinical aspects of epilepsy, and other professionals interested in seizure disorders.
The Society holds an Annual Meeting which features symposia, lectures, poster presentations, and exhibitions. This meeting offers members a forum for communicating and disseminating current findings in the field of epilepsy. The meeting attracts over 4,500 professionals and offers excellent opportunities for networking and sharing of ideas.
There will be two awards given in the amount of $10,000 each. These awards will be made to active scientists and clinicians. Our program is available to investigators working in all aspects of epilepsy.
The awards are intended as prizes, and as such they will be made to individuals for their unrestricted use. Funds are for the exclusive use of the recipients and may not be used for institutional or departmental support. There is no provision for institutional overhead. AES reserves the right to determine the number of awards, based on available funds and other considerations.
Any individual holding a professional degree and whose research impacts on any aspect of epilepsy is eligible for these awards.
• There is no geographic restriction. Nominations from outside the U.S. and North America are welcome.
• Nominations of women and members of minority groups are especially encouraged.
• Nominee must be at least at level of Associate Professor or Professor.
• A strong preference will be given to members of the Society.
Selection of Awardees
The American Epilepsy Society has the sole responsibility for selection of recipients, based upon recommendations of an Awards Committee appointed by the President and Board of Directors of the Society. Recipients will be selected competitively from each category. No individual may receive more than one award from each category. More than one nomination may be submitted from a single institution. Members of the Awards Committee are ineligible for consideration.
Applications are evaluated based on the following criteria: 1) Pioneering research, 2) Originality of research, 3) Quality of publications, 4) Research productivity, 5) Relationship of the candidate's work to problems in epilepsy, 5) Training activities, 6) Other contributions in epilepsy, and 7) Productivity over the next decade.
How To Apply
Please submit the candidate package to the American Epilepsy Society. The Cover Form may be reproduced. A single electronic document (Word or PDF) should be compiled with the following documents and sent to the AES Executive Office, email@example.com. The deadline for receipt of candidate packages is August 1, 2014.
Awards will be announced at the Annual Meeting of the American Epilepsy Society in Seattle, WA, December 2014
A complete proposal consists of a single electronic file with the following:
• Cover Form with candidate contact information. Be sure to indicate either basic or clinical category.
• One letter of support with commentary on the quality of the candidate's work and the importance of his/her contributions.
• CV, including bibliography. Candidate should ensure that all activities and affiliations are included. Candidate's biography should list consulting relationships, advisory board memberships, or executive positions with institutions other than the candidate's identified institutional affiliation.
• A personal statement of candidate's current research program and accomplishments. Include explanation of research and likely future directions. Please note: This summary should be a descriptive overview, not a research proposal or excerpts from a grant application.
• Reprints of three representative publications
Call for Nominations: 2015 American Society for Biochemistry and Molecular Biology Awards
The 2015 award nomination deadline is May 19, 2014
The ASBMB Award for Exemplary Contributions to Education is given annually to a scientist who encourages effective teaching and learning of biochemistry and molecular biology through his/her own teaching, leadership in education, writing, educational research, mentoring or public enlightenment. Nominations must be originated by Society members, but the nominees need not be ASBMB members. The Award will consist of a cash prize of $3,000, and the winner will present a plenary symposium lecture at the 2015 ASBMB Annual meeting.
The ASBMB-Merck Award recognizes outstanding contributions to research in biochemistry and molecular biology. Nominations must be originated by Society members, but the nominees need not be ASBMB members. The Award consists of a plaque, $5,000, transportation, and expenses of the recipient and spouse to the 2015 ASBMB Annual Meeting to present a lecture.
The ASBMB Young Investigator Award recognizes outstanding research contributions to biochemistry and molecular biology. The recipient must have no more than 15 years postdoctoral experience. Nominations must be originated by Society members, but nominees need not be ASBMB members. The Award consists of a plaque, $5,000, transportation, and expenses to present a lecture at the 2015 ASBMB Annual Meeting.
The Avanti Award in Lipids recognizes outstanding research contributions in the area of lipids. Nominations must be originated by Society members, but the nominees need not be ASBMB members. The Award consists of a plaque, $3,000, and transportation and expenses to present a lecture at the 2015 ASBMB Annual Meeting.
The Alice and C. C. Wang Award in Molecular Parasitology will recognize established investigators who are making seminal contributions to the field of molecular parasitology at the time of the award. Novel and significant discoveries on the biology of parasitic organisms are of particular emphasis. The areas of research to be awarded are limited to protozoan parasites, but otherwise broadly defined, including, but not limited to, biochemistry, molecular biology, gene regulation, metabolism, cell biology, development biology and host-pathogen interactions. Nominations must be originated by ASBMB members and self nominations are acceptable. The Award recipient should be an internationally recognized scientific leader who has already made important discoveries in the field and continues an active effort at the cutting edge of research. The Award will consist of $35,000 for use by the recipient’s research laboratory, a plaque, and travel expenses for the recipient to attend the ASBMB Annual Meeting to present a lecture on his or her work. In addition, the winner of the award will organize a half-day symposium at the ASBMB national meeting focusing on molecular Parasitology.
The Bert and Natalie Vallee Award in Biomedical Science was established by the Bert and N. Kuggie Vallee Foundation in 2012 to recognize international achievements in the sciences basic to medicine. It is awarded to an established scientist for outstanding accomplishments in basic biomedical research. Nominations must originate from ASBMB members; however, the nominee need not be an ASBMB member. The Award consists of a $10,000 cash award, a plaque and travel expenses for attendance at the ASBMB Annual Meeting to present a lecture.
The DeLano Award for Computational Biosciences was established by family, friends and colleagues to honor the legacy of Warren L. DeLano. The award will be given to a scientist for the most accessible and innovative development or application of computer technology to enhance research in the life sciences at the molecular level. The contribution should include two key elements - more productive use of computers to accelerate and facilitate research, and ready access of these programs for the scientific community. Nominations must originate from ASBMB members, but the nominee need not be an ASBMB member. The Award consists of a plaque, a $3,000 cash award and travel expenses for the recipient to attend the ASBMB annual meeting to present a lecture.
The Earl and Thressa Stadtman Distinguished Scientist Award was established by friends and colleagues to preserve their legacies as scientists and mentors. It is awarded to an established scientist for his or her outstanding achievement in basic research in the fields encompassed by the ASBMB. The award will be given every other year, alternating with The Earl and Thressa Stadtman Young Scholar Award. Nominations must originate from ASBMB members, but the nominee need not be an ASBMB member. The Award consists of a plaque, a $10,000 cash award and travel expenses for the ASBMB Annual Meeting to present a lecture. The Earl and Thressa Stadtman Distinguished Scientist Award will be given in 2015.
The Herbert Tabor Research Award The Herbert Tabor Research Award has been established by the American Society for Biochemistry and Molecular Biology to recognize the many contributions of Dr. Herbert Tabor to the Journal of Biological Chemistry and the Society. The award will be given for excellence in biological chemistry and molecular biology and the contributions to the community of scientists. ASBMB seeks to be the first to recognize outstanding contributions. Nominations must originate from ASBMB members and the nominee must be a member of ASBMB. The award consists of a $30,000 research award, a plaque and travel expenses for the ASBMB Annual Meeting to present a lecture.
The Mildred Cohn Award in Biological Chemistry was established to honor the pioneering scientific accomplishments and the spirit of the late Professor Cohn. Dr. Cohn was the first female president of ASBMB, at the time known as the American Society of Biological Chemists. The Award recognizes and honors scientists at all stages of their careers that have made substantial advances in understanding biological chemistry using innovative physical approaches. Nominations must be originated by Society members, but the nominees need not be ASBMB members. The Award will be given annually and consists of an award$5,000 and travel expenses to the ASBMB Annual Meeting to present the Mildred Cohn Award lecture.
The Ruth Kirschstein Diversity in Science Award was established to honor an outstanding scientist who has shown a strong commitment to the encouragement of under-represented minorities to enter the scientific enterprise and/or to the effective mentorship of those within it. The award will consist of a plaque, a cash prize of $3,000, and transportation expenses to present a lecture at the annual ASBMB meeting. The recipient will be chosen by the Minority Affairs Committee. Nominations must be originated by Society members; however, the nominee need not be an ASBMB member.
The Walter A. Shaw Young Investigator Award in Lipid Research, established by ASBMB’s Lipid Research Division, recognizes outstanding research contributions in the area of lipids by young investigators who are an Assistant professor or equivalent and with no more than 10 years of experience since receiving their degree (PhD and/or MD). Nominations must be originated by Society members, but the nominees need not be ASBMB members. Self nominations are acceptable. The award consists of a plaque, $2,000 and transportation and expenses to present a lecture at the 2015 ASBMB Annual Meeting.
The William C. Rose Award recognizes outstanding contributions to biochemical and molecular biological research and a demonstrated commitment to the training of younger scientists, as epitomized by the late Dr. Rose. Nominations must be originated by Society members, but the nominees need not be ASBMB members. The Award consists of a plaque, $3,000, and transportation to the 2015 ASBMB Annual Meeting to present a lecture.
Society of Critical Care Medicine Vision Grant
The Society's Vision Grant offers up to $50,000 in funding to members conducting basic, translational or clinical research specifically related to the organization's mission to secure the highest quality care for all critically ill and injured patients.
SCCM seeks to sponsor research efforts that will ultimately improve patient care in the ICU. Investigator-initiated research should help advance and improve our understanding of critical illness and patient care.
Interest is broad. Applications are encouraged that focus on expanding our basic knowledge of critical illness, clinical interventions to improve patient outcomes, technical aspects - such as electronic surveillance systems -- as well as studies exploring cultural and educational factors among ICU staff that either impede or facilitate a climate promoting best practice and error reduction. Priority will be given to projects that have broad relevance. Single-center projects, for example, should specifically address the potential to generalize their findings to other critical care settings.
Submission and Deadline
APPLICATION SUBMISSION DEADLINE: AUGUST 11, 2014.
One electronic copy of the application must be received by August 11, 2014.
Please submit the electronic copy to Vision Grant, utilizing the "Request a delivery receipt" and "Request a read receipt" functions.
All submissions are to be in PDF format and compiled as one document.
The principal investigator must be a current SCCM member and maintain SCCM membership through the life of the grant. Applications are encouraged from junior and established investigators. Applications from junior investigators (defined as no prior independent NIH funding - RO1 or equivalent - and within 10 years of finishing their training) may request independent support or may include a research mentor who is also an SCCM member and can demonstrate strong research credentials in the areas of clinical and outcomes research. Previous recipients of the Vision Grant may not reapply for a period of five years from the date of the previous grant award.
American Society of Hematology Scholar Awards
The ASH Scholar Awards are designed to support hematologists who have chosen a career in research by providing partial salary or other support during that critical period required for completion of training and achievement of status as an independent investigator.
Awards are limited to a maximum of $100,000 for fellow scholars and $150,000 for junior faculty scholars over a two- to three-year period, with an annual maximum of $50,000 for fellows and $75,000 for junior faculty. Up to 15 percent of the award can be (but is not required to be) used for benefits, including medical and dental insurance, life insurance, and retirement benefits.
All awards are activated on July 1 of the following year. The applicant has the option of concluding the award on June 30, two or three years after activation. All award payments are made on a quarterly basis - the amount depends on whether the award is being spread over two or three years. Payments are made to the appropriate financial officer of the institution as indicated on the proposed budget within the full application.
ASH considers basic research to include a broad spectrum of studies on genes, proteins, lipids, carbohydrates, biochemical and signaling pathways, receptors, cells and animals, as well as samples obtained from humans, all of which are designed to further our understanding of the blood, bone marrow, and related organs or the pathogenesis of blood disorders. The emphasis for grants in this category should be on the discovery of new knowledge in a traditional laboratory setting.
ASH defines translational research as using knowledge of human biology to develop and test the feasibility of relevant interventions in humans and/or determine the biological basis for observations made in individuals with hematologic conditions or in populations at risk. Translational research should be founded on and directly connected to some aspect of human biology and may encompass any form of structural, biochemical, genetic, or other appropriate experimental approaches using human materials. The proposal should address clinical applications - not just test development - although the development of novel instrumentation of value to hematology is clearly within the scope of the application. Clinical trial projects with laboratory correlatives are considered clinical.
Clinical Research: ASH considers clinical/translational research to include patient-oriented research and outcomes-based research. ASH emphasizes that clinical research must involve substantial interaction with patients.
For the purposes of the ASH Scholar Awards program, patient-oriented research is defined as research conducted with human subjects and involves an investigator directly interacting with human subjects. Categories of patient-oriented research include: 1) mechanisms of human disease, 2) therapeutic interventions, 3) clinical trials, and 4) development of new technologies.
ASH strongly encourages applications in outcomes-based research. Options for outcomes-based research include: 1) a decision-analysis or cost-effectiveness analysis of a relevant topic within hematology, 2) survey-based research investigating practice patterns, access to care, quality of care, clinical outcomes, or quality of life among patients with hematologic conditions, 3) retrospective analyses of large administrative databases (e.g., CMS, a large insurer, SEER) that may enlighten health care policy decisions related to hematologic disease, and 4) large scale epidemiologic or genetic epidemiologic studies that define the incidence, prevalence, prognosis, and natural history or the effects of therapy of blood disorders.
Applications that fall within any of the categories discussed above are encouraged.
Letter of Intent Due: Wednesday, May 7, 2014
Application Made Available for Those Who Successfully Submit a LOI by the Deadline: Thursday, June 5, 2014
Application Deadline Friday, August 1, 2014
Award Winners Notified: Mid-November, 2014
Activation of Award: Wednesday, July 1, 2015
These eligibility requirements are evaluated as of the date of the LOI submission.
Eligible applicants must be a citizen of the United States or Canada or hold a visa in the United States or Canada.
Eligible applicants must conduct research within the US or Canada
Scholar Award applicants are required to be members of ASH in good standing at the time of the Letter of Intent submission, and for the duration of the Scholar Award Program. If your membership application is pending at the time of the Scholar Award application deadline, you will still be considered for a Scholar Award.
To verify your membership status, please log on to the membership section of the ASH website. If you need assistance with your username and password, please contact an ASH Customer Relations Representative at firstname.lastname@example.org.
Fellow Scholar Awards
PhD or MD/PhD applicants must have fewer than 5 years of research experience after completion of their PhD (including research performed during fellowship, but excluding clinical fellowship time)
MD applicants should have more than 3 but fewer than 5 years of research experience (including research performed during fellowship, but excluding clinical fellowship time)
MD applicants with fewer than 3 years research experience (inclusive of fellowship research time) should consider applying for the Senior RTAF award
Applicants with the title of Assistant Professor or equivalent *must* apply for the Junior Faculty Award, regardless of research experience
Junior Faculty Scholar Awards
MD, PhD or MD/PhD applicants must have more than 5 but fewer than 10 years of research experience after completion of their PhD (including research performed during fellowship, but excluding clinical fellowship time)
Applicants with the title of Assistant Professor or equivalent *must* apply for the Junior Faculty Award, regardless of research experience.
American Society of Hematology Bridge Grant Program
All applicants must submit proposals to conduct research in hematology.
ASH considers basic research to include a broad spectrum of studies on genes, proteins, lipids, carbohydrates, biochemical and signaling pathways, receptors, hematopoietic cells, and samples obtained from human patients or from vertebrate animal models. For the purpose of this grant, hematology-related basic research is designed to further our understanding of the blood, bone marrow, and related organs and/or the pathogenesis of blood disorders. The emphasis for grants in this category should be on the discovery of new knowledge in a traditional laboratory setting.
ASH defines translational research as using knowledge of human biology to develop and test the feasibility of relevant interventions in humans and/or determine the biological basis for observations made in individuals with hematologic conditions or in populations at risk. Translational research should be founded on and directly connected to some aspect of human biology and may encompass any form of structural, biochemical, genetic, or other appropriate experimental approaches using human materials.
Patient-Oriented Clinical Research
Patient-oriented research is defined as research conducted with human subjects and involves an investigator directly interacting with human subjects. Categories of patient-oriented research include: 1) mechanisms of human disease, 2) therapeutic interventions, 3) clinical trials, and 4) development of new technologies.
Options for outcomes-based research include: 1) a decision-analysis or cost-effectiveness analysis of a relevant topic within hematology, 2) survey-based research investigating practice patterns, access to care, quality of care, clinical outcomes, or quality of life among patients with hematologic conditions, 3) retrospective analyses of large administrative databases (e.g., CMS, a large insurer, SEER) that may enlighten health-care policy decisions related to hematologic disease, and 4) large scale epidemiologic or genetic epidemiologic studies that define the incidence, prevalence, prognosis, and natural history or the effects of therapy of blood disorders.
Application deadline: June 1, 2014
Application notification of acceptance: Mid-Late July, 2014
To be eligible for the ASH Bridge Grant Award all applicants must:
Have submitted a hematology-related R01 or equivalent application to NIH in the past 18 months that was scored but not funded.
ASH uses the NIH definition of R01 equivalence: “R01-equivalent awards include R01, R23, R29, and R37 activity codes and, beginning in fiscal year 2008, DP2 awards to first-time NIH investigators. Not all of these activities are in use by NIH every year.”
The 18 month timeline is linked specifically to the date your R01 was reviewed by the NIH study section.
Be an ASH member or have a pending application for membership at the time of application.
If you have a pending application and are awarded a Bridge Grant Award, your award will be conditional based upon membership approval
Hold a faculty position in an academic institution or the equivalent position in a non-profit research organization. Employees of independent research institutions are eligible to apply if they have a faculty type appointment and the institution is allowed to independently apply for and receive NIH funding.
At the time of award activation, the amount of other research funding available to the principal investigator may not exceed $250,000 annually. This amount does not include the applicant’s salary/fringe and funding from within the institution.
Hematologists eligible to apply for the ASH Scholar Award are not eligible to apply for this award.
Individuals cannot hold an ASH Scholar Award and ASH Bridge Grant concurrently. ASH Scholars can apply if their award terminates before the commencement of the bridge grant.
Applicants can apply a maximum of three times over the three-year award program.
Previous Bridge Grant award recipients cannot apply for a second award.